Skip to main content
TipRanks
Go Ultimate75% OFF

Innate Pharma SA (IPH) Q4 2018 Earnings Report

10 Followers

FR:IPH Q4 2018 EPS Results

Actual EPS
EUR 0.31
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.43

FR:IPH Q4 2018 Revenue Results

Actual Revenue
EUR 63.01M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2018
Date
05/15/2019
Time
Before Open
Conference Call
Wednesday, May 15, 2019
FR:IPH Upcoming Earnings

Innate Pharma SA's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q4 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

FR:IPH Earnings History

FR:IPH earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.10--0.31――
Sep 17, 20262026 (Q2)-0.16-0.21-0.2516.00% (+0.04)
Mar 26, 20262025 (Q4)-0.12-0.31-0.310.00% (+0.00)
Sep 17, 20252025 (Q2)-0.28-0.25-0.3119.35% (+0.06)
Mar 27, 20252024 (Q4)-0.26-0.31-0.12-158.33% (-0.19)
Sep 12, 20242024 (Q2)-0.28-0.310.02-1650.00% (-0.33)
Mar 21, 20242023 (Q4)-0.40-0.12-0.8185.19% (+0.69)
Sep 14, 20232023 (Q2)0.080.020.08-75.00% (-0.06)
Mar 23, 20232022 (Q4)-0.39-0.81-0.35-131.43% (-0.46)
Sep 15, 20222022 (Q2)0.330.08-0.3126.67% (+0.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed